Investment Analysts’ Weekly Ratings Updates for Alphatec (ATEC)

Alphatec (NASDAQ: ATEC) recently received a number of ratings updates from brokerages and research firms:

• 1/27/2026 – Alphatec had its “buy” rating reaffirmed by analysts at TD Cowen.
• 1/23/2026 – Alphatec was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 1/12/2026 – Alphatec had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $24.00 price target on the stock.
• 1/12/2026 – Alphatec had its “buy” rating reaffirmed by analysts at Needham & Company LLC. They now have a $22.00 price target on the stock.
• 1/7/2026 – Alphatec had its price target raised by analysts at Barclays PLC from $23.00 to $27.00. They now have an “overweight” rating on the stock.
• 1/3/2026 – Alphatec was upgraded by analysts at Wall Street Zen from a “hold” rating to a “buy” rating.
• 12/29/2025 – Alphatec had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – Alphatec had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – Alphatec had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/10/2025 – Alphatec was given a new $25.00 price target on by analysts at Loop Capital.
• 12/8/2025 – Alphatec had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
• 12/6/2025 – Alphatec was downgraded by analysts at Wall Street Zen from a “buy” rating to a “hold” rating.
• 12/2/2025 – Alphatec was given a new $23.00 price target on by analysts at Morgan Stanley.
• 12/1/2025 – Alphatec had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.

Insider Buying and Selling at Alphatec

In related news, major shareholder Jennifer N. Pritzker sold 250,000 shares of the stock in a transaction on Monday, November 24th. The stock was sold at an average price of $20.62, for a total value of $5,155,000.00. Following the completion of the transaction, the insider directly owned 10,895,045 shares of the company’s stock, valued at approximately $224,655,827.90. This represents a 2.24% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, major shareholder Squadron Capital Llc sold 250,000 shares of the firm’s stock in a transaction on Monday, November 24th. The shares were sold at an average price of $20.62, for a total value of $5,155,000.00. Following the completion of the transaction, the insider owned 10,895,045 shares in the company, valued at $224,655,827.90. The trade was a 2.24% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 3,233,342 shares of company stock valued at $66,688,781 over the last ninety days. Corporate insiders own 20.90% of the company’s stock.

Alphatec Holdings, Inc (NASDAQ: ATEC) is a medical technology company focused on the design, development and commercialization of products for the surgical correction of degenerative spinal conditions. The company’s portfolio centers on interbody implants, biologics, fixation devices and surgical planning tools intended to improve patient outcomes in spinal fusion procedures. Alphatec’s flagship offerings include customizable interbody cages, bone graft materials and specialized instrumentation designed for minimally invasive and open spinal surgeries.

Founded as Alphatec Spine in 1985 and rebranded as Alphatec Holdings in 2018, the company has grown from a single-product organization into a multi-platform innovator in the spine market.